Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-27

Clinical Trial Update: Effect of GSK3640254 on the Pharmacokinetics of a Combination Oral Contraceptive [Phase 1]

View source ↗

Summary

Phase 1 trial assessing how GSK3640254 affects the pharmacokinetics of a combination oral contraceptive; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Combination oral contraceptive
  • GSK3640254

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2020-08-27